In Japan the average age of male chronic dialysis patients has gradually risen. Recently, the reports of male chronic dialysis patients with prostate cancer have been observed sporadically. Then, serum PSA screening was conducted to detect prostate cancer in male chronic dialysis patients with a low daily urine volume and minor complaints regarding voiding symptoms.
Sixty-six male chronic hemodialysis patients were included. The average patient age was 60.1 years old (from 37 to 83 years), their average hemodialysis period was 5.6 years (from 0.3 to 16.4 years). The serum PSA values were measured using the Tosoh PA II kit.
Serum PSA values ranged from 0.1 to 40.4ng/m
l, but only 3 patients' serum PSA values were over 4ng/m
l. In these 3 patients, transrectal prostate biopsy was performed under ultrasonic guidance. As result, prostate cancer was detected in 2 patients, but these patients had neither lymph node metastasis nor distant metastasis. The serum PSA screening was very effective for the early detection of prostate cancer in these 2 patients, because they had low daily urine volume and minor complaints related to voiding symptoms. In this study, the prostate cancer detection rate was 3% (2/66 patients). Except for the 2 prostate cancer patients, there was no correlation recognized between the hemodialysis period and serum PSA value, ages and serum PSA values in 64 patients. Based on these results, it is suggested that the serum PSA value in chronic hemodialysis patients is not affected by hemodialysis therapy.
View full abstract